Table 1 Characteristics of the included patients
Total | 30d AMI or death | Neither AMI nor death | p-values*** | |
|---|---|---|---|---|
n (%) | 9519 (100.0) | 804 (8.4) | 8715 (91.6) | |
Female, % | 47.3 | 35.1 | 48.4 | < 0.01 |
Age, mean (std) | 59.1 (18.9) | 71.7 (12.9) | 57.9 (18.9) | < 0.01 |
Disease history* | ||||
Acute myocardial infarction, % | 11.1 | 19.7 | 10.3 | < 0.01 |
Congestive heart failure, % | 8.6 | 14.9 | 8.0 | < 0.01 |
Peripheral vascular disease, % | 3.7 | 7.8 | 3.4 | < 0.01 |
Cerebral vascular accident, % | 6.4 | 8.8 | 6.2 | < 0.01 |
Dementia, % | 0.9 | 1.2 | 0.8 | 0.205 |
Pulmonary disease, % | 11.3 | 11.3 | 11.2 | 0.95 |
Connective tissue disorder, % | 2.9 | 3.9 | 2.8 | 0.095 |
Liver disease, % | 0.2 | 0.4 | 0.2 | 0.426 |
Diabetes, % | 10.7 | 17.8 | 10.1 | < 0.01 |
Diabetes complications, % | 4.5 | 9.2 | 4.1 | < 0.01 |
Renal Disease, % | 3.2 | 6.2 | 2.9 | < 0.01 |
Cancer, % | 8.4 | 12.7 | 8.0 | < 0.01 |
Metastatic cancer, % | 1.4 | 2.6 | 1.3 | < 0.01 |
Severe liver disease, % | 0.1 | 0.1 | 0.1 | 0.586 |
Biomarkers | ||||
Glucose mmol/L, median (IQR) | 6.1 (5.5–7.2) | 7.2 (6.1–9) | 6.1 (5.5–7.0) | < 0.01 |
Hb g/L, mean (std) | 139.4 (16.4) | 138.2 (20.1) | 139.5 (16.0) | 0.064 |
Creatinine (μmol/L), median (IQR) | 78 (66–92) | 85.5 (71–105) | 77 (66–91) | < 0.001 |
hs-cTnT (ng/L), median (IQR) | 6 (4–15) | 52 (22–159) | 6 (4–12) | < 0.001 |
hs-cTnT sample time, median (IQR)** | 30.0 (17.0–49.0) | 20.0 (10.0–36.0) | 30.0 (17.0–50.0) | < 0.001 |